TURINETTO, MARGHERITA
 Distribuzione geografica
Continente #
NA - Nord America 458
EU - Europa 198
AS - Asia 150
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 813
Nazione #
US - Stati Uniti d'America 447
IT - Italia 80
SG - Singapore 71
IE - Irlanda 40
CN - Cina 36
SE - Svezia 24
ID - Indonesia 12
DE - Germania 10
FR - Francia 10
CA - Canada 8
HK - Hong Kong 8
VN - Vietnam 7
JP - Giappone 6
KR - Corea 5
UA - Ucraina 5
FI - Finlandia 4
NG - Nigeria 4
PT - Portogallo 4
RO - Romania 4
LU - Lussemburgo 3
MX - Messico 3
CZ - Repubblica Ceca 2
ES - Italia 2
GB - Regno Unito 2
HR - Croazia 2
NL - Olanda 2
RU - Federazione Russa 2
TR - Turchia 2
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
GR - Grecia 1
IN - India 1
MA - Marocco 1
MY - Malesia 1
TW - Taiwan 1
Totale 813
Città #
Chandler 94
Singapore 57
Dublin 40
Turin 29
Ashburn 25
Santa Clara 22
Fairfield 18
Nyköping 18
Columbus 15
Seattle 14
Jakarta 12
Rome 12
Cambridge 9
Woodbridge 9
Princeton 7
Torino 7
Houston 6
Munich 6
New York 6
Boston 5
Hong Kong 5
Medford 5
Wilmington 5
Abuja 4
Ann Arbor 4
Boardman 4
Dong Ket 4
Genoa 4
Milan 4
Montréal 4
Nanjing 4
Upper Marlboro 4
Apodaca 3
Guangzhou 3
Jacksonville 3
Lappeenranta 3
Naples 3
San Jose 3
Seoul 3
Tianjin 3
Toulouse 3
Turda 3
Avellino 2
Beijing 2
Brno 2
Carate Brianza 2
Chicago 2
Coimbra 2
Edmonton 2
Fidenza 2
Fremont 2
Kamiokubo 2
Lille 2
Madrid 2
Milwaukee 2
Montreal 2
Moscow 2
Paris 2
Redwood City 2
Riverton 2
Rochester 2
San Diego 2
Split 2
St Louis 2
São João da Madeira 2
Wuhan 2
Amstelveen 1
Antalya 1
Barendrecht 1
Basel 1
Breitenfelde 1
Bristol 1
Buenos Aires 1
Changsha 1
Chaoyang 1
Chengdu 1
Cleveland 1
Cluj-Napoca 1
Cologno Monzese 1
East Durham 1
Eau Claire 1
Filderstadt 1
Fiumicino 1
Gainesville 1
Guanzate 1
Hangzhou 1
Hebei 1
Hefei 1
Helsinki 1
Ho Chi Minh City 1
Los Angeles 1
Lyon 1
Nuremberg 1
Parma 1
Pittsburgh 1
Pune 1
Quanzhou 1
Reston 1
San Mateo 1
San Mauro Torinese 1
Totale 574
Nome #
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience 121
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 120
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy 116
The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality 59
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey 56
Biomarkers of central nervous system involvement from epithelial ovarian cancer 54
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time? 52
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers 49
ASO Visual Abstract: Clinical and Histopathologic Predictors Signaling Recurrence of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers 41
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study 34
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 23
Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers 22
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report 19
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 19
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial 19
Uterine smooth muscle tumors: a multicenter, retrospective, comparative study of clinical and ultrasound features 16
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors 12
Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors 5
763P Treatment response to non-platinum therapies in ovarian cancer patients according to BRCA status: A retrospective analysis of a large multicentric cohort 4
Totale 841
Categoria #
all - tutte 4.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 10 35 9 5 10 3 3 1 6 2 14
2021/202299 6 3 5 2 4 4 2 2 5 10 28 28
2022/2023274 19 24 7 28 34 59 12 19 28 6 25 13
2023/2024201 22 31 9 20 13 27 7 8 4 13 16 31
2024/2025169 5 31 22 43 68 0 0 0 0 0 0 0
Totale 841